PIN1 and acute promyelocytic leukemia: To demonstrate the cooperation and translational significance of ATO and ATRA in targeting Pin1 for treating cancers, we chose TNBC as a model system because unlike APL, which is basically cured by ATO and ATRA10–12, TNBC has the worst prognosis of all breast cancer subtypes and no targeted therapy is available59.